| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yoshiaki Shoji, Kazuo Koyanagi, Kohei Kanamori, Kohei Tajima, Mika Ogimi, Kentaro Yatabe, Miho Yamamoto, Akihito Kazuno, Kazuhito Nabeshima, Kenji Nakamura, Takayuki Nishi and Masaki Mori |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kazuo Koyanagi, FACS, MD, PhD, Chairman, Professor, Department of Gastroenterological Surgery, Tokai University School of Medicine, 143, Shimokasuya, Isehara 259-1193, Japan. kkoyanagi@tsc.u-tokai.ac.jp |
| Key Words |
Esophagogastric junction cancer; Perioperative therapy; Neoadjuvant therapy; Surgery; Multidisciplinary treatment |
| Core Tip |
In recent years, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Recent developments of perioperative multidisciplinary treatment led to increased patient outcomes. In this review, we will focus on the current status and future perspectives of the perioperative treatment including chemotherapy, radiation therapy, targeted therapy, and immunotherapy, as well as the surgical strategy for locally advanced esophagogastric adenocarcinoma. Better understanding of the latest treatment strategy and future overlook may lead to better prognosis for the patients. |
| Publish Date |
2023-06-28 10:03 |
| Citation |
Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Yatabe K, Yamamoto M, Kazuno A, Nabeshima K, Nakamura K, Nishi T, Mori M. Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review. World J Gastroenterol 2023; 29(24): 3758-3769 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i24/3758.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i24.3758 |
